Dexamethasone: chondroprotective corticosteroid or catabolic killer?
While glucocorticoids have been used for over 50 years to treat rheumatoid and osteoarthritis pain, the prescription of glucocorticoids remains controversial because of potentially harmful side effects at the molecular, cellular and tissue levels. One member of the glucocorticoid family, dexamethaso...
Main Authors: | Black, Robert Xavier, Grodzinsky, Alan J |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | English |
Published: |
European Cells and Materials
2020
|
Online Access: | https://hdl.handle.net/1721.1/126296 |
Similar Items
-
Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis
by: Black, Rebecca M., et al.
Published: (2022) -
Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term
by: Bajpayee, Ambika Goel, et al.
Published: (2017) -
Chondroprotective Effect of Zerumbone on Monosodium Iodoacetate Induced Osteoarthritis in Rats
by: Al-Saffar, F. J., et al.
Published: (2010) -
Evaluation of chondroprotective activity of Channa striatus in rabbit osteoarthritis model
by: Abdul Kadir, Azidah, et al.
Published: (2019) -
Awarenness of corticosteroid glaucoma
by: , Adi S. Affandi
Published: (2010)